Dr. Ross Camidge discusses a clinical trial studying patients with advanced stage lung cancer to identify those who may respond to a drug called ponatinib. Both small cell and non small cell lung cancer patients may be eligible.
Advertisement
Clinical Trial Spotlight_ Identifying Lung Cancer Patients Who Respond to Ponatinib [360p]
